Primoteston Depot (Testosterone)

Quick links

Choose a section

Quick links to important sections

Advertisements

Primoteston Depot (Testosterone)

Advertisements
Advertisements

Treatment option: Hypogonadism

Advertisements

Overview of Primoteston Depot (Testosterone)

Property Description
Active ingredient Testosterone Enanthate (INN)
Form Solution for injection (Oily solution)
Pharmacological class Androgen, Anabolic Steroid
Common use Androgen Replacement Therapy
Origin Synthetic derivative (Esterified)

What Type of Medicine is Primoteston Depot (Testosterone)?

Primoteston Depot is an injectable prescription medicine classified as an Androgen and an Anabolic Steroid. Its core component is Testosterone Enanthate, a synthetic ester derivative of the primary male sex hormone, Testosterone. This substance is applied in addressing conditions of hormone deficiency. The medication’s use is defined as Androgen Replacement Therapy, intended to restore and maintain physiological hormone levels in men.

The specific Testosterone Enanthate compound functions as a prodrug that undergoes hydrolysis following administration to release active Testosterone into the bloodstream. As an Androgen Receptor Agonist, it activates Testosterone receptors in various body tissues.

Formulation and Mechanism: Why is it a "Depot" Injection?

The medication is formulated as a clear, yellowish oily solution for injection, intended exclusively for deep Intramuscular injection. The combination of the enanthate ester and the oil base enables the formation of a pharmacological reservoir, or "depot," within the muscle tissue, which is a key characteristic of its design.

This design ensures a Sustained Hormone Release profile, allowing the hormone to be absorbed slowly over an extended period. The primary general purpose of this long-acting formulation is to provide continuous hormonal support, thereby maintaining the systemic functions dependent on Testosterone without the significant peaks and troughs associated with shorter-acting forms.

Regulatory References

  1. TGA ARTG ID 10707
  2. DailyMed on Testosterone Enanthate Injection
  3. DailyMed Label for Testosterone Enanthate Injection
Advertisements

What side effects are possible with Primoteston Depot (Testosterone)?

Possible Side Effects and Safety Information

The safety profile of testosterone enanthate is defined by officially documented adverse reactions classified by frequency and system involvement, as reported in governmental regulatory documents.

Classification of Documented Adverse Reactions

The side effects associated with this therapy are organized into System Organ Classes (SOCs). Reactions listed as Common (expected in 1/100 to < 1/10 patients) frequently involve Blood and Lymphatic System Disorders and Investigations, including increases in haemoglobin and haematocrit (red blood cell measures) and an increase in Prostate Specific Antigen ( PSA). Other common effects may include acne, gynecomastia (breast enlargement), headache, and pain at the injection site.

Serious Adverse Reactions and Safety Constraints

Regulatory information highlights the potential for serious adverse reactions. These include the risk of Venous Thromboembolism (VTE), which involves the formation of blood clots. The therapy is also associated with fluid retention, which can lead to edema and congestive heart failure in patients with pre-existing cardiac, renal, or hepatic disease.

Specific constraints include a contraindication for men with known or suspected prostate or breast carcinoma. For safety surveillance, the official labeling mandates the periodic monitoring of haematocrit/haemoglobin levels and PSA concentrations.

Population-Specific Safety Notes

The label specifies risks for certain populations. In older adults, there is an increased risk for prostatic hyperplasia and prostate carcinoma. In pediatric patients, androgen use can cause accelerated bone maturation, potentially limiting final adult height. Furthermore, certain effects, such as polycythaemia (high red blood cell count), are noted to be associated with long-term exposure to androgen therapy.

Advertisements

Overdose and Emergency Response

Officially Documented Manifestations of Overdose

The overdose profile for Primoteston Depot is defined primarily by the manifestation of exaggerated pharmacological effects (signs of hormone excess) rather than acute toxicity from a single event. According to official regulatory documents, an acute over-dosage is generally unlikely to require specific treatment beyond discontinuation of the product.

However, signs of over-dosage or chronic over-exposure mandate immediate medical review and action. Documented clinical manifestations of over-dosage include:

  • Priapism: The occurrence of too frequent or persistent/prolonged erections. This is a critical sign requiring product withdrawal.
  • Oedema: Increased fluid retention and swelling. This complication is noted as potentially more serious in patients with preexisting cardiac, renal, or hepatic disease.
  • Polycythaemia: Laboratory evidence of elevated haematocrit and haemoglobin, indicating an increase in red blood cell mass that requires clinical intervention.

Emergency Action and Treatment

The primary regulatory-mandated action when clinical or laboratory signs of androgen excess are reported is the withdrawal or discontinuation of the medicinal product. Patients must seek immediate medical attention for confirmed or suspected over-dosage, particularly if severe symptoms such as sustained priapism or significant fluid retention occur. High-dose use or abuse is officially associated with serious cardiovascular and psychiatric adverse reactions. The documented management for over-exposure is limited to symptomatic and supportive treatment, as regulatory information confirms that no specific antidote is known for a testosterone overdose.

Advertisements

Therapeutic Uses of Primoteston Depot (Testosterone)

What Primoteston Depot (Testosterone) Treats: Main Uses and Benefits

Primoteston Depot (Testosterone Enanthate) is used as an Androgen Replacement Therapy (ART) to manage symptoms related to systemic imbalance caused by confirmed testosterone deficiency, a condition generally known as male hypogonadism. The medication is considered relevant in situations where patients experience deficiency or absence of endogenous testosterone, such as confirmed Primary Hypogonadism or Hypogonadotropic Hypogonadism.

The therapy helps address symptom clusters that may become intense or disruptive, including pronounced fatigue, reduced sexual desire (libido), hormonal contribution to erectile dysfunction, and the physical strain leading to loss of muscle mass and bone density. The therapy supports the general well-being during symptomatic phases by assisting with the maintenance of hormone levels considered physiological, which plays a role in managing symptoms related to chronic hormonal lack. This provides supportive relief when symptoms interfere with routine activities, contributing to easing the overall symptom load.

“The treatment supports the patient during difficult episodes by helping manage symptom clusters that may become intense or disruptive.”


Quick Fact: Relief for Chronic Fatigue This medication is commonly used to help with persistent low energy and low mood, assisting with maintaining functional stability.

Regulatory References

  1. FDA Drug Label for Testosterone Enanthate
Advertisements

Eligibility and Restrictions for Use

Eligibility for Primoteston Depot (Testosterone Enanthate)

This medicine is authorized for use strictly in adult males diagnosed with confirmed conditions of endogenous testosterone deficiency, such as Primary or Hypogonadotropic Hypogonadism.

Absolute Contraindications

The medicine must not be used in several populations, as officially documented. This includes men with known or suspected carcinoma of the prostate or carcinoma of the breast. Use is also strictly contraindicated in women who are pregnant or may become pregnant, due to documented risks of fetal harm. Furthermore, use is prohibited in patients with known hypersensitivity to any product components and in men with previous or existing liver tumors.

Restricted and Age-Related Eligibility

Eligibility is subject to official warnings and restrictions. The safety and efficacy of Primoteston Depot are not established in males under 18 years of age, and use in this group carries the risk of premature bone maturation. It is not recommended for age-related hypogonadism alone. Caution is required for patients with pre-existing cardiac, renal, or hepatic disease due to the potential for fluid retention. Close monitoring is also necessary for men with Benign Prostatic Hyperplasia (BPH) and those with uncontrolled hypertension.

Advertisements

What should I know about interactions with other medicines?

This regulatory profile outlines formally documented interaction patterns for Primoteston Depot (Testosterone Enanthate) as specified in official government prescribing information. The clinically significant interactions documented relate to pharmacodynamic effects and metabolic alterations rather than complex pharmacokinetic mechanisms involving metabolic enzymes.

Documented Interaction Categories

  • Oral Anticoagulants: Co-administration of androgens may change, specifically increasing, the anticoagulant activity of medicines like Warfarin. This documented effect requires frequent monitoring of the International Normalized Ratio (INR) and prothrombin time, as defined by official constraints.
  • Corticosteroids and ACTH: Combining testosterone with Corticosteroids or Adrenocorticotropic Hormone (ACTH) is officially documented to result in a pharmacodynamic effect of increased fluid retention. This potential for fluid accumulation is officially noted as a specific concern for individuals with underlying cardiac, renal, or hepatic disease.
  • Antidiabetic Drugs: The official label states that androgens may exert a metabolic impact that decreases blood glucose levels. This change can subsequently decrease the required dose of Insulin or other antidiabetic medicines for patients with established diabetes.

No mandatory timing-based separation requirements for administration or specific interactions with food, alcohol, or herbal products are explicitly cited within the regulatory drug interaction sections reviewed.

Advertisements

Mechanism of Action

Primoteston Depot delivers Testosterone, which functions as an agonist at the intracellular Androgen Receptor (AR), initiating changes in cellular activity. The long-acting depot formulation ensures the hormone is released slowly, providing a sustained engagement of these biological processes over an extended duration.

Genomic and Anabolic Signaling

The core mechanism involves the AR binding the active hormone, causing the receptor complex to translocate to the cell nucleus. Once in the nucleus, it acts as a transcription factor, modulating gene expression by binding to specific DNA sites. This action drives the anabolic pathway, resulting in enhanced protein synthesis and nitrogen retention, contributing to the growth and mineralization of skeletal tissue.

Metabolic Diversification and Feedback Control

Testosterone is subject to enzymatic modification by two key enzymes: 5alpha-reductase and Aromatase. 5alpha-reductase converts it into the biologically active androgen, Dihydrotestosterone (DHT), which has a high receptor affinity, while Aromatase converts it into the estrogen E2, which contributes to the regulation of skeletal mineralization. Furthermore, the presence of the exogenous hormone engages the Hypothalamic-Pituitary-Testicular Axis (HPTA) in a negative feedback loop, a physiological constraint that suppresses the body's natural production of LH and FSH.

Advertisements

Dosage and Administration Information

How to Use Primoteston Depot (Testosterone)

The administration of Primoteston Depot is performed as a deep intramuscular injection only. The medication is formulated as an oily solution, commonly supplied at a strength of 250 mg of testosterone enantate per 1 mL ampoule. The oily base and ester compound facilitate the formation of a pharmacological reservoir within the muscle tissue, which determines the extended dosing schedule.

Dosing and Frequency Patterns

The treatment protocol involves an individualized, long-term approach for androgen replacement. The starting dose for adults is typically 250 mg, which also serves as the standard maintenance dose. The initial phase involves the injection being administered more frequently, such as every 2 to 3 weeks, to establish therapeutic hormone levels. The subsequent maintenance interval is generally extended to every 3 to 4 weeks, although intervals may extend up to 6 weeks.

This frequency is not fixed; the exact timing of the next injection is determined by professional monitoring of an individual's serum testosterone concentration.

Administration Technique and Adjustments

The injection is administered extremely slowly into the gluteal muscle, and care is taken to strictly avoid intravascular injection. The solution must be visually inspected before use to confirm it is clear and free from particles. While no specific dose adjustment is noted for older adults, a distinct regimen exists for males with delayed puberty, which involves a smaller dose (e.g., 50 mg to 200 mg) administered over a limited course of 4 to 6 months.

Advertisements

Recent Clinical Evidence

Primoteston Depot (Testosterone): Recent Clinical Evidence

Research evidence for Primoteston Depot (testosterone enanthate) is primarily based on studies for testosterone replacement therapy in men diagnosed with primary or secondary hypogonadism (testosterone deficiency related to certain medical conditions). The evidence is drawn mainly from randomized controlled trials (RCTs) and long-term observational registries.


Hormone Restoration and Physical Parameters

Clinical research has explored patterns of hormone concentration, reporting that the drug helps maintain serum total testosterone levels within the mid-normal physiological range for the duration of the dosing interval, consistent with its sustained-release profile. Studies have also examined changes in body composition, reporting patterns observed in measurements of Lean Body Mass (LBM) and Body Fat Mass (BFM) over the course of the trials. Findings related to self-reported measures of sexual function and vitality have been mixed, showing variability across different studies and populations.


Metabolic and Long-Term Research

Research has explored the effects on metabolic markers, including changes in glucose metabolism and lipid profiles. While some studies describe changes in these parameters, the long-term effect on patient-important outcomes related to cardiovascular health or mortality is not well characterized by short-term trials. Data from extended observational registries track the maintenance of hormone levels and bone mineral density (BMD) over several years.


Research Gaps and Limitations

Key limitations across the evidence base include short follow-up durations in many core RCTs, which prevents definitive conclusions on long-term safety and efficacy. Many findings rely on surrogate endpoints (like BMD or LBM) rather than direct evidence showing a change in major clinical events, such as fracture incidence. Data for certain specific groups, including men with multiple co-existing conditions, remain insufficient, and comparative evidence against other treatments is often lacking or uncertain.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Primoteston Depot (Testosterone) (FAQ)

Q: How quickly does Primoteston Depot start working after the injection?

Pharmacokinetic studies show that blood levels are described as beginning to rise within approximately one to three days after the injection. The design of this depot formulation is intended to provide sustained levels over several weeks. However, the timeframe for an individual to notice changes in clinical symptoms, such as energy or mood, can vary.

Q: Can Primoteston Depot cause changes in mood or energy levels?

Official drug labels list potential psychiatric side effects, including the risk of experiencing changes in mood such as depression, anxiety, and irritability. While changes in energy levels are often a goal of therapy for deficiency, they are not uniformly listed as a specific adverse reaction in official safety documents.

Q: Do I need special tests before I can start using Primoteston Depot?

Yes, regulatory and medical guidelines require that the diagnosis of testosterone deficiency (hypogonadism) is officially confirmed before starting treatment. This typically involves collecting blood samples in the morning on at least two separate days to measure serum total testosterone levels, to determine if blood levels meet the criteria required for diagnosis.

Q: Can Primoteston Depot affect my cholesterol or blood pressure?

Official documents indicate that testosterone therapy is associated with the potential for increased blood pressure, which is a factor healthcare professionals may track during treatment. Additionally, official labeling notes that androgens, like those in Primoteston Depot, can cause changes in lipid profiles (cholesterol levels).

Q: Is it normal to feel a brief change in energy right after the injection?

Primoteston Depot is specifically formulated for slow, extended hormone release, which is intended to prevent sharp peaks in hormone levels. While the FDA notes the potential for acute post-injection reactions, official documentation does not typically describe or confirm the anecdotal experience of a brief 'energy spike' immediately after administration.

Q: Do I need to inform my doctor about all my vitamins and supplements when using Primoteston Depot?

The general safety requirement is that healthcare professionals be made aware of all medications, vitamins, and supplements being used. While official labels list specific drug-drug interactions (such as with anticoagulants), this disclosure is necessary to safely manage potential unknown interactions that may affect the overall treatment plan.

Q: Is Primoteston Depot known to affect liver function?

Yes, official product information indicates the potential for hepatic adverse effects (effects on the liver). Cases of cholestatic jaundice and abnormal liver function tests have been reported, and the medication is strictly contraindicated for patients with known or suspected liver tumors.

Q: What are the general expectations for results after a few months of use?

Clinical study timelines suggest that maximizing potential benefits related to body composition (muscle and fat mass) and bone density is generally observed after six months or longer of continuous treatment. Improvements in sexual interest may begin earlier, often in the first month.

Q: Does the time of day the injection is given matter for Primoteston Depot?

Official administration instructions for this long-acting injection emphasize the correct dose and the specific dosing interval (e.g., every 3 to 4 weeks). Due to its extended 'depot' effect, the specific time of day of the injection is not generally noted as a clinical factor impacting efficacy or monitoring, unlike some daily medications.

Q: Is there any public research available about patient experiences with Primoteston Depot?

While regulatory documents do not feature patient surveys directly, the evidence base for testosterone therapy includes Patient-Reported Outcomes (PROs). These are standardized measures, such as quality-of-life and sexual function scores, that are used in clinical trials to evaluate a patient’s perceived benefit and experience during treatment.

Q: How is the need for Primoteston Depot treatment confirmed by a doctor?

Guidelines require the combination of clinical symptoms and laboratory confirmation for diagnosis. This confirmation typically involves specific testing protocols, such as measuring total testosterone levels from at least two separate morning blood samples that consistently show levels below the established normal range.

Q: Is Primoteston Depot the same as other testosterone injections I've heard of?

No, it is not the same. Primoteston Depot contains Testosterone Enanthate, which is a specific form of testosterone. While chemically similar to other common injectables like Testosterone Cypionate, the specific ester compound influences the drug’s absorption, release rate, and, consequently, the required dosing schedule.

Q: What is the difference between Primoteston Depot and testosterone gel?

The key difference lies in the delivery method and hormone release profile. Primoteston Depot is an intramuscular injection (depot) given infrequently. Testosterone gels are transdermal preparations applied daily, which are associated with a different profile of hormone stability but also carry the risk of accidental transfer to other people.

Q: Is it true that Primoteston Depot can affect fertility?

Yes, official labeling notes that testosterone replacement therapy can potentially impair fertility. This is because it may cause a reduction in sperm count. In some individuals, this effect is stated to be potentially permanent.

Q: What are some common misunderstandings about using Primoteston Depot?

Medical literature clarifies several common misunderstandings. A key clarification often found in medical literature notes that current data does not support the historical concern that testosterone therapy causes or promotes prostate cancer in men with a normal baseline prostate. Regulatory bodies also issue cautions regarding the inappropriate use of testosterone for non-approved purposes.

Q: Does Primoteston Depot interact with common over-the-counter pain relievers?

The official product labeling specifically documents interactions with medications like Warfarin, corticosteroids, and antidiabetic drugs. However, the regulatory text does not explicitly cite common non-prescription pain relievers, such as non-steroidal anti-inflammatory drugs (NSAIDs), as having an official interaction.

Q: What happens if a dose of Primoteston Depot is missed?

The official product information does not include standard 'missed dose' instructions because the treatment schedule is personalized and adjusted based on monitored blood levels. Official guidance is that any deviation from the planned injection interval necessitates professional review to adjust the treatment plan.

Q: Can Primoteston Depot affect sleep patterns?

Yes, official labeling for testosterone replacement therapy includes a warning that it may worsen pre-existing or developing sleep apnea. This risk is noted to be greater in patients who have other risk factors, such as obesity or chronic lung conditions.

Q: What is the difference between low testosterone and testosterone deficiency in official terms?

In medical terms, low testosterone simply refers to an abnormal lab result. Testosterone deficiency (or hypogonadism) is the formal medical condition recognized for replacement therapy, and it is diagnosed when a low blood level is confirmed alongside the presence of specific clinical signs and symptoms.

Q: Why do official guidelines stress that testosterone injections are only for confirmed deficiency?

The FDA mandates this restriction because the drug's approved indication is limited to men with deficiency due to specific medical conditions (primary or secondary hypogonadism). The use of testosterone for age-related decline alone is not approved and is associated with warnings about the risk of serious side effects.

Q: How does the TGA or FDA classify the safety profile of Primoteston Depot?

In the United States, testosterone enanthate is officially classified as a Schedule III controlled substance under the DEA Controlled Substances Act. This classification is assigned due to the drug’s accepted medical use but also recognizes its potential for abuse or dependence.

Q: Why is it described that Primoteston Depot should not be used for bodybuilding or athletic enhancement?

Official drug labels contain clear warnings against the abuse of testosterone at high doses for non-medical reasons, such as increasing muscle mass and improving athletic performance. This type of misuse is strongly cautioned against because it can lead to serious cardiovascular, endocrine, and psychiatric adverse reactions.

Q: What are the signs of a high red blood cell count, as described in official documents?

A high red blood cell count, known as polycythemia or erythrocytosis, is a known risk monitored through routine blood tests checking hematocrit and hemoglobin levels. While specific patient-facing symptoms are not consistently listed on product labels, clinical reviews associate high red blood cell counts with an increased risk of blood clots, which may cause symptoms such as pain or swelling.

Q: Can Primoteston Depot affect hair loss or growth?

Yes, official safety information indicates that testosterone replacement therapy is associated with certain effects on hair. This can include the development of androgenic alopecia (male pattern hair loss) and, conversely, hirsutism (excessive body hair growth) in some individuals.

Q: What is the difference between testosterone cypionate and testosterone enanthate?

Both are long-acting injectable forms of testosterone, but they possess slightly different ester chains attached to the testosterone molecule. This subtle difference in chemical structure results in minor variations in the drug's half-life and rate of release, although both are generally used with comparable dosing intervals.

Q: Can Primoteston Depot be detected in standard drug screening tests?

General workplace drug screening tests typically do not look for testosterone or its synthetic forms. However, specialized tests, such as those used in sports or anti-doping contexts, can detect the presence of administered testosterone or an abnormally high Testosterone-to-Epitestosterone ratio in a urine sample.

Advertisements

How should Primoteston Depot (Testosterone) be stored and disposed of?

How to Store and Dispose of Primoteston Depot (Testosterone)

The official requirements for storing and disposing of Primoteston Depot are established in regulatory labeling to maintain product stability and safety.

Official Storage Conditions

Requirement Category Description
Temperature and Light Store below 25 C in a cool, dry place. The product must be protected from light, including direct sunlight.
Prohibited Environments Do not store near heat or dampness, such as in a car, near a sink, or in a bathroom.
Packaging Keep the medicine in its original pack until immediately before use; do not use if the packaging is damaged.
Child Safety Store Primoteston Depot strictly out of the reach and sight of children, preferably in a locked cupboard.

Disposal Requirements

Any unused, expired, or damaged Primoteston Depot must be returned to a pharmacist for safe and proper disposal. The product must not be placed in household trash or discarded into wastewater.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Primoteston Depot (Testosterone) found in:

A-Z Index: